Intermittent Androgen Deprivation Therapy-An Important Treatment Option for Prostate Cancer

被引：12
作者：
Klotz, Laurence [1 ]
Higano, Celestia S. [2 ,3 ]
机构：
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Urol, Toronto, ON, Canada
[2] Univ Washington, Fred Hutchinson Canc Res Ctr, Sch Med, Div Med Oncol,Dept Med, Seattle, WA 98195 USA
[3] Univ Washington, Fred Hutchinson Canc Res Ctr, Sch Med, Dept Urol, Seattle, WA 98195 USA
来源：
JAMA ONCOLOGY | 2016年 / 2卷 / 12期
关键词：
SUPPRESSION;
D O I：
10.1001/jamaoncol.2016.3138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1531 / 1532
页数：2
相关论文
共 12 条
  • [1] Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist
    Albertsen, Peter C.
    Klotz, Laurence
    Tombal, Bertrand
    Grady, James
    Olesen, Tine K.
    Nilsson, Jan
    [J]. EUROPEAN UROLOGY, 2014, 65 (03) : 565 - 573
  • [2] BRUCHOVSKY N, 1990, CANCER RES, V50, P2275
  • [3] The role of intermittent androgen suppression in biochemically recurrent or newly diagnosed metastatic prostate cancer
    Crook, Juanita
    [J]. CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2013, 7 (03) : 258 - 264
  • [4] Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
    Crook, Juanita M.
    O'Callaghan, Christopher J.
    Duncan, Graeme
    Dearnaley, David P.
    Higano, Celestia S.
    Horwitz, Eric M.
    Frymire, Eliot
    Malone, Shawn
    Chin, Joseph
    Nabid, Abdenour
    Warde, Padraig
    Corbett, Thomas
    Angyalfi, Steve
    Goldenberg, S. Larry
    Gospodarowicz, Mary K.
    Saad, Fred
    Logue, John P.
    Hall, Emma
    Schellhammer, Paul F.
    Ding, Keyue
    Klotz, Laurence
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (10) : 895 - 903
  • [5] Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer
    Hershman, Dawn L.
    Unger, Joseph M.
    Wright, Jason D.
    Ramsey, Scott
    Till, Cathee
    Tangen, Catherine M.
    Barlow, William E.
    Blanke, Charles
    Thompson, Ian M.
    Hussain, Maha
    [J]. JAMA ONCOLOGY, 2016, 2 (04) : 453 - 461
  • [6] Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group trial 9346 (INT-0162)
    Hussain, Maha
    Tangen, Catherine M.
    Higano, Celestia
    Schelhammer, Paul F.
    Faulkner, James
    Crawford, E. David
    Wilding, George
    Akdas, Atif
    Small, Eric J.
    Donnelly, Bryan
    MacVicar, Gary
    Raghavan, Derek
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3984 - 3990
  • [7] Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the Details
    Hussain, Maha
    Tangen, Catherine
    Higano, Celestia
    Vogelzang, Nicholas
    Thompson, Ian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (03) : 280 - U147
  • [8] Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
    Hussain, Maha
    Tangen, Catherine M.
    Berry, Donna L.
    Higano, Celestia S.
    Crawford, E. David
    Liu, Glenn
    Wilding, George
    Prescott, Stephen
    Sundaram, Subramanian Kanaga
    Small, Eric Jay
    Dawson, Nancy Ann
    Donnelly, Bryan J.
    Venner, Peter M.
    Vaishampayan, Ulka N.
    Schellhammer, Paul F.
    Quinn, David I.
    Raghavan, Derek
    Ely, Benjamin
    Moinpour, Carol M.
    Vogelzang, Nicholas J.
    Thompson, Ian M., Jr.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (14) : 1314 - 1325
  • [9] KLOTZ LH, 1986, CANCER-AM CANCER SOC, V58, P2546, DOI 10.1002/1097-0142(19861201)58:11<2546::AID-CNCR2820581131>3.0.CO
  • [10] 2-N
12